Marksans Pharma Limited

Web: marksanspharma.com NSE: MARKSANS BSE: 524404 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

326 6(-2%)

Near 52W High of 346

Volume

49L as on 23, Jun

Open

294

High

300

Low

293

332

VWAP

264

52 Week High

346

52 Week Low

155

Viand Research Rating

Quality Score

67/100

Growth Score

64/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

14,794

No. of Shares

45.3

P/E

99.07

P/B

11.79

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

11.89

ROCE

Profit Growth

Listing Date

21-Jan-02

Promoter Holding

43.87%

FII Holding

17.47%

DII Holding

6.19%

Price Chart

Price Performance

1 Week8%

1 Month26%

3 Months66%

6 Months53%

1 Year53%

YTD53%

Moving Average

5 Day SMA260

10 Day SMA254

20 Day SMA249

30 Day SMA236

50 Day SMA216

61 Day SMA207

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	270	259	266	270
Resistance 2	266	258	262	266
Resistance 1	261	257	260	262
Pivot Point	257	256	257	257
Support 1	252	255	253	253
Support 2	248	254	251	248
Support 3	243	254	248	244

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 43.87%	(0.01) 43.87%	(0.01) 43.87%	(0.01) 43.87%	(0.01) 43.87%	(0.01) 43.87%	(0.01) 43.87%	(0.01) 43.87%	(0.01) 43.87%	(0.01) 43.85%	(0.01) 43.85%	(0.01) 43.85%	(0.01) 43.85%	(-5.21) 43.85%	(0.41) 49.00%	(0.41) 48.60%	(0.01) 48.25%	(0.01) 48.25%	(0.01) 48.25%	(0.01) 48.25%
FIIs	(0.71) 17.47%	(8.61) 16.76%	(-8.81) 8.13%	(-3.01) 16.92%	(-2.31) 19.89%	(0.21) 22.19%	(0.61) 21.95%	(2.71) 21.31%	(3.01) 18.59%	(0.01) 15.57%	(0.51) 15.55%	(0.21) 15.07%	(-0.21) 14.90%	(10.91) 15.11%	(0.21) 4.23%	(0.01) 4.06%	(0.61) 4.04%	(0.91) 3.46%	(-0.11) 2.59%	(0.01) 2.64%
DIIs	(-0.41) 6.19%	(0.71) 6.57%	(0.61) 5.91%	(-0.21) 5.28%	(1.01) 5.50%	(0.31) 4.55%	(0.21) 4.30%	(0.41) 4.10%	(-1.41) 3.75%	(0.41) 5.17%	(0.71) 4.76%	(0.41) 4.02%	(2.21) 3.65%	(0.51) 1.46%	(0.01) 0.96%	(0.01) 0.95%	(0.51) 0.94%	(0.11) 0.47%	(-0.11) 0.41%	(0.01) 0.53%
Public	32.46%	32.78%	42.08%	33.93%	30.74%	29.37%	29.88%	30.70%	33.77%	35.40%	35.81%	37.06%	37.60%	39.57%	45.79%	46.38%	46.77%	47.82%	48.75%	48.58%
No. of Shareholders	246,635	246,279	255,153	265,788	256,221	257,273	259,813	248,845	235,500	254,699	237,377	207,937	188,447	198,382	213,123	217,743	221,359	220,090	214,998	201,451

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	841	856	754	720	620	708	682	642	591	560	586	531	500	486	480	453	434	418	363	361	349
Sales Growth % (YoY)	35.6%	20.8%	10.6%	12.2%	5%	26.5%	16.3%	20.8%	18.1%	15.2%	22.2%	17.4%	15.3%	16.2%	32.3%	25.3%	24.3%	26.6%	1.2%	1.3%	5.4%
Sales Growth % (QoQ)	-1.8%	13.5%	4.7%	16.1%	-12.4%	3.8%	6.2%	8.6%	5.5%	-4.4%	10.4%	6.2%	2.9%	1.2%	6%	4.4%	3.8%	15.2%	0.6%	3.4%	-
Expenses	628	661	594	576	520	582	543	495	462	450	453	417	398	376	403	372	361	354	305	301	272
Operating Profit	213	195	161	144	100	127	139	147	128	110	133	114	102	110	77	80	73	64	58	60	77
OPM %	25	23	21	20	16	18	20	23	22	20	23	21	20	23	16	18	17	15	16	17	22
Other Income	25	35	20	22	6	15	28	0	15	17	5	19	10	11	18	14	16	15	12	9	6
Interest	7	6	6	6	6	3	3	3	3	5	3	2	2	2	2	3	2	5	1	2	1
Depreciation	25	24	24	27	23	23	21	20	20	21	22	18	14	14	13	14	11	21	9	7	7
Profit before tax	207	200	151	133	77	116	143	125	120	100	113	114	97	104	79	78	76	53	60	60	75
Tax %	23	25	25	26	24	22	27	22	26	23	26	26	27	21	21	23	21	44	20	23	16
Net Profit	159	149	114	99	58	91	105	98	89	78	83	84	70	83	62	60	60	30	48	46	63
Net Profit Growth % (QoQ)	6.7%	30.7%	15.2%	70.7%	-36.3%	-13.3%	7.1%	10.1%	14.1%	-6%	-1.2%	20%	-15.7%	33.9%	3.3%	-	100%	-37.5%	4.3%	-27%	-
Net Profit Growth % (YoY)	174.1%	63.7%	8.6%	1%	-34.8%	16.7%	26.5%	16.7%	27.1%	-6%	33.9%	40%	16.7%	176.7%	29.2%	30.4%	-4.8%	-	-	-	-
TTM Net Profit	521	420	362	353	352	383	370	348	334	315	320	299	275	265	212	198	184	187	157	109	0
EPS in Rs	3.47	3.27	2.5	2.17	1.29	2	2.31	2.13	1.96	1.73	1.84	1.84	1.52	1.81	1.57	1.51	1.46	0.69	1.18	1.11	1.53

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	2951	2623	2177	1852	1491	1376	1134	1000	913	767	893	797	630	438
Sales Growth %	12.5%	20.5%	17.6%	24.2%	8.3%	21.3%	13.4%	9.6%	19%	-14.1%	12.1%	26.5%	43.7%	23.3%
Expenses	2350	2090	1719	1513	1232	1037	942	868	834	722	757	612	512	369
Operating Profit	601	533	459	340	259	340	192	132	78	45	136	185	118	69
OPM %	20	20	21	18	17	25	17	13	9	6	15	23	19	16
Other Income	82	66	50	59	42	7	0	5	8	7	9	3	4	4
Interest	24	12	11	9	8	8	9	10	10	7	10	16	19	15
Depreciation	99	83	74	52	45	36	27	23	27	30	28	16	16	16
Profit before tax	561	504	424	338	248	302	157	104	50	15	107	156	86	44
Tax %	25	24	26	21	25	21	23	23	28	24	23	28	15	-12
Net Profit	420	383	315	265	187	239	121	80	36	11	83	112	74	49
Net Profit Growth %	9.7%	21.6%	18.9%	41.7%	-21.8%	97.5%	51.2%	122.2%	227.3%	-86.7%	-25.9%	51.4%	51%	-
EPS in Rs	9.22	8.4	6.92	5.88	4.51	5.76	2.95	1.87	0.8	0.22	1.92	2.67	1.87	1.19
Dividend Payout %	10	10	9	9	6	4	3	3	6	23	21	4	5	10

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	458	207	230	237	99	179	233	27	50	14	31	155	65	39
Cash from Investing Activity	-249	-49	-141	-259	-84	-45	-60	-13	-39	-21	-123	-33	-4	-5
Cash from Financing Activity	-71	-65	-69	198	80	-15	-114	-21	3	-3	-58	17	-29	-40
Net Cash Flow	138	93	21	176	94	118	60	-7	15	-10	-150	138	31	-7

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	45	45	45	45	45	45	41	41	41	41	41	41	41	41	39	39
Reserves	2978	2643	2422	2236	2020	1700	1161	846	595	502	430	392	401	326	90	34
Borrowings	343	332	322	198	244	123	111	34	30	100	118	110	100	101	173	176
Other Liabilities	489	422	451	432	372	322	323	307	236	160	142	209	180	207	188	152
Total Liabilities	3856	3442	3240	2911	2681	2190	1636	1228	902	802	731	752	722	676	490	401
Fixed Assets	1044	1054	982	787	776	486	428	309	303	270	279	267	270	166	146	156
CWIP	59	7	27	11	9	10	3	12	0	0	0	0	0	0	0	0
Investments	0	1	1	15	27	1	0	0	0	0	0	0	0	0	0	0
Other Assets	2753	2381	2230	2098	1869	1694	1205	907	599	533	451	484	452	510	344	245
Total Assets	3856	3442	3240	2911	2681	2190	1636	1228	902	802	731	752	722	676	490	401

Delivery

Delivery Data: MARKSANS

#	Date	240 44% 346	Value (Cr)	Q/T 74	Del 32	Del 78
1	4-Sep	327	54	65	35	19
2	3-Sep	332	91	57	36	33
3	2-Sep	332	219	78	28	61
4	1-Sep	322	45	57	43	19
5	31-Aug	322	79	50	44	35
6	28-Aug	330	48	54	36	17
7	27-Aug	326	46	58	39	18
8	26-Aug	331	65	56	41	27
9	25-Aug	318	54	59	29	16
10	24-Aug	324	58	47	36	20
11	21-Aug	321	83	62	34	28
12	20-Aug	321	63	67	33	21
13	19-Aug	327	85	78	29	24
14	18-Aug	326	109	83	27	30
15	17-Aug	331	436	93	16	71
16	14-Aug	333	659	105	19	122
17	13-Aug	303	332	98	17	57
18	12-Aug	313	1487	124	10	149
19	11-Aug	279	40	58	48	19
20	10-Aug	271	18	51	46	8
21	7-Aug	274	28	48	48	13
22	6-Aug	269	34	54	49	17
23	5-Aug	271	24	48	44	10
24	4-Aug	269	35	59	45	16
25	3-Aug	262	17	36	54	9
26	31-Jul	258	18	34	51	9
27	30-Jul	259	17	32	55	9
28	29-Jul	259	18	51	44	8
29	28-Jul	257	24	45	47	11
30	27-Jul	263	62	64	40	25
31	24-Jul	246	20	38	39	8
32	23-Jul	246	43	61	36	16
33	22-Jul	241	104	70	37	39
34	21-Jul	260	55	47	45	24
35	20-Jul	267	20	24	48	10
36	17-Jul	267	38	39	43	16
37	16-Jul	275	35	40	46	16
38	15-Jul	276	47	66	39	18
39	14-Jul	271	39	62	42	16
40	13-Jul	269	30	63	46	14
41	10-Jul	272	60	70	52	31
42	9-Jul	277	126	77	40	50
43	8-Jul	263	101	77	38	39
44	7-Jul	261	41	46	47	19
45	6-Jul	260	36	63	43	15
46	3-Jul	264	35	52	44	15
47	2-Jul	267	36	47	41	15
48	1-Jul	269	52	58	41	21
49	30-Jun	273	69	80	44	30
50	29-Jun	263	58	82	34	20

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	14,794c	342c	2.26
03-Sep	15,136c	605c	4.16
01-Sep	14,531c	25c	0.17
31-Aug	14,506c	261c	1.76
27-Aug	14,766c	82c	0.55
26-Aug	14,848c	406c	2.81
25-Aug	14,442c	206c	1.41
24-Aug	14,649c	222c	1.54
21-Aug	14,427c	431c	2.90
19-Aug	14,857c	70c	0.48
18-Aug	14,787c	190c	1.27
17-Aug	14,977c	242c	1.59
14-Aug	15,220c	1,366c	9.86
13-Aug	13,853c	181c	1.29
12-Aug	14,035c	1,579c	12.68
11-Aug	12,455c	252c	2.06
10-Aug	12,204c	159c	1.28
06-Aug	12,362c	181c	1.49
05-Aug	12,181c	224c	1.88
04-Aug	11,957c	265c	2.27
31-Jul	11,692c	111c	0.94
30-Jul	11,803c	36c	0.31
29-Jul	11,766c	102c	0.87
28-Jul	11,664c	304c	2.54
27-Jul	11,968c	0	0

Stock Checklist

Price is above from 52 week high low average: 90%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 41 fund scheme(s) across 11 fund house(s) as of Aug26 · Total value ₹941 Cr · 17 increasing / 12 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
UTI Mutual Fund	12	0.96%	+0.07%	448.4
Kotak Mahindra Mutual Fund	6	2.56%	-0.78%	225.3
Bandhan Mutual Fund	6	0.34%	+0.08%	194.2
Motilal Oswal Mutual Fund	4	0.60%	+0.03%	29.6
JM Financial Mutual Fund	2	1.20%	+0.06%	19.4
Old Bridge Mutual Fund	2	3.05%	-	12.8
Unifi Mutual Fund	2	1.93%	+0.75%	8.8
Jio BlackRock Mutual Fund	1	0.07%	+0.07%	2.2
Groww Mutual Fund	2	0.03%	+0.01%	0.2
Angel One Mutual Fund	2	0.03%	+0.01%	0
Mirae Asset Mutual Fund	2	0.02%	+0.01%	0

Marksans Pharma Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements